SCD and cancer: SCD1 was shown to be significantly overexpressed in T98G-R and U87-R cells and to drive their resistance to TMZ by stimulating the Akt/GSK3β/β-catenin signaling pathway, which is relevant for cancer cell survival and the invasive phenotype.